APOE and amyloidosis: Of all the tested variables, age, positive amyloidosis, APOE ε4 presence, and cognitive status significantly correlated with the plasma pTau181 levels, which appeared to increase with positive amyloidosis, APOE ε4 presence, age above 70 years, and an MMSE score below 25 (Fig. 3A, Table S6).